Barchart & Kalshi Announce Partnership on Event Markets
The strategic partnership will integrate Kalshi markets, data and content throughout Barchart, giving you more information for decision-making.
/Fedex%20Corp%20cargo%20planes-by%20Teka77%20via%20iStock.jpg)
After a strong second-quarter earnings showing, BlackBerry is now turning the spotlight to its upcoming third-quarter earnings this month.
/Quantum%20Computing/Image%20by%20Funtap%20via%20Shutterstock.jpg)
Luminar Technology has filed for bankruptcy and announced the sale of Luminar Semiconductors to Quantum Computing.
Both Ford and GM are outperforming the markets in 2025. However, GM looks like a better buy between the two, given the company's recent track record on execution.
Mid-America Apartment Communities’ stock has underperformed the S&P 500 over the past year, but analysts are moderately bullish about its prospects.
Canopy Growth soars on reports the White House is considering reclassifying cannabis as a “Schedule III” drug. Here’s why CGC shares currently look attractive as a long-term holding.
SRx Health stock soars as the company announces a major crypto pivot. But investors are cautioned against chasing the momentum in SRXH shares heading into 2026.
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
STX is being added to the Nasdaq-100 when it reconstitutes next week.
Affirm shares rally as the fintech confirms it has extended its partnership with Amazon through 2031. Here’s what makes AFRM stock worth owning for 2026.
SNDL stock rallies on reports President Donald Trump will soon reclassify marijuana as Schedule III drug. Analysts expect SNDL shares to more than double from here in 2026.
MSTR was being eyed for possible Nasdaq-100 removal, but when the index reconstitutes next week, it will get to stay. Other companies, including Biogen and Lululemon, will be removed.
